Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
HIV Medicine
|
September 17, 2004
Significance of hepatitis C virus coinfection with persistently normal alanine aminotransferase levels in HIV-1-infected patients
L Fonquernie, L Serfaty, A Charrois, et al.
Gastroenterologie Clinique Et Biologique
|
April 27, 2010
Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone
N Rabahi, Y Chrétien, F Gaouar, et al.
Journal of Internal Medicine
|
November 30, 2005
HHV-6-related acute liver failure in two immunocompetent adults: favourable outcome after liver transplantation and/or ganciclovir therapy
W Cacheux, N Carbonell, O Rosmorduc, et al.
Lipids
|
July 27, 1999
Targeting of cytosolic phospholipase A2 to plasma membrane inhibits its activation by G-protein coupled receptors
E Klapisz, M Ziari, K Koumanov, et al.
Journal De Radiologie
|
November 1, 1996
[Imaging of symptomatic giant hemangioma]
T Bouras, L Arrivé, L Monnier-Cholley, et al.
Gastroenterologie Clinique Et Biologique
|
April 12, 2008
Phenotypic expression of ferroportin disease in a family with the N144H mutation
O Rosmorduc, D Wendum, L Arrivé, et al.
Journal of Clinical Pathology
|
December 3, 2003
Immunohistochemical analysis of adenocarcinoma of the small intestine: a tissue microarray study
M Svrcek, F Jourdan, N Sebbagh, et al.
European Journal of Biochemistry
|
October 16, 1999
N-terminal and C-terminal plasma membrane anchoring modulate differently agonist-induced activation of cytosolic phospholipase A2
E Klapisz, M Ziari, D Wendum, et al.
AIDS (London, England)
|
October 16, 2001
Impact of early-untreated HIV infection on chronic hepatitis C in intravenous drug users: a case-control study
L Serfaty, D Costagliola, D Wendum, et al.
Hepatology (Baltimore, Md.)
|
November 26, 1999
Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium
F Lakehal, D Wendum, V Barbu, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
HIV Medicine
|
September 17, 2004
Significance of hepatitis C virus coinfection with persistently normal alanine aminotransferase levels in HIV-1-infected patients
L Fonquernie, L Serfaty, A Charrois, et al.
Gastroenterologie Clinique Et Biologique
|
April 27, 2010
Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone
N Rabahi, Y Chrétien, F Gaouar, et al.
Journal of Internal Medicine
|
November 30, 2005
HHV-6-related acute liver failure in two immunocompetent adults: favourable outcome after liver transplantation and/or ganciclovir therapy
W Cacheux, N Carbonell, O Rosmorduc, et al.
Lipids
|
July 27, 1999
Targeting of cytosolic phospholipase A2 to plasma membrane inhibits its activation by G-protein coupled receptors
E Klapisz, M Ziari, K Koumanov, et al.
Journal De Radiologie
|
November 1, 1996
[Imaging of symptomatic giant hemangioma]
T Bouras, L Arrivé, L Monnier-Cholley, et al.
Gastroenterologie Clinique Et Biologique
|
April 12, 2008
Phenotypic expression of ferroportin disease in a family with the N144H mutation
O Rosmorduc, D Wendum, L Arrivé, et al.
Journal of Clinical Pathology
|
December 3, 2003
Immunohistochemical analysis of adenocarcinoma of the small intestine: a tissue microarray study
M Svrcek, F Jourdan, N Sebbagh, et al.
European Journal of Biochemistry
|
October 16, 1999
N-terminal and C-terminal plasma membrane anchoring modulate differently agonist-induced activation of cytosolic phospholipase A2
E Klapisz, M Ziari, D Wendum, et al.
AIDS (London, England)
|
October 16, 2001
Impact of early-untreated HIV infection on chronic hepatitis C in intravenous drug users: a case-control study
L Serfaty, D Costagliola, D Wendum, et al.
Hepatology (Baltimore, Md.)
|
November 26, 1999
Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium
F Lakehal, D Wendum, V Barbu, et al.
Page
of 5